C12N 2502/115
Platelets, megakaryocytes
C12N2502/115 (Platelets, megakaryocytes) appears on 45 US grants and 136 published applications in this corpus.
Search patents in C12N- Granted patents
- 45
- Published applications
- 136
- Assignees
- 91
- Inventors
- 277
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 3 |
| 2010 | 0 | 1 |
| 2011 | 0 | 4 |
| 2012 | 0 | 5 |
| 2013 | 2 | 2 |
| 2014 | 1 | 5 |
| 2015 | 1 | 9 |
| 2016 | 0 | 3 |
| 2017 | 4 | 6 |
| 2018 | 0 | 8 |
| 2019 | 4 | 6 |
| 2020 | 3 | 7 |
| 2021 | 3 | 8 |
| 2022 | 1 | 17 |
| 2023 | 2 | 15 |
| 2024 | 5 | 16 |
| 2025 | 10 | 13 |
| 2026 | 8 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for manufacturing mitochondria-rich plasma22 Sep 2026US 12,741,068 B2Taiwan Mitochondrion Applied Technology Co., Ltd.
- NK cell compositions and preparations for immunotherapy and methods for their production16 Jun 2026US 12,655,190 B2Deverra Therapeutics Inc.
- Compositions and methods related to megakaryocyte-derived extracellular vesicles for treating myeloproliferative neoplasms2 Jun 2026US 12,644,134 B2STRM.bio Incorporated
- Systems and methods for preservation of cells19 May 2026US 12,628,820 B2University of Louisville Research Foundation, Inc.
- Use of a cell culture composition for promoting cell growth19 May 2026US 12,629,460 B2Taiwan Mitochondrion Applied Technology Co., Ltd.
- Induction/differentiation medium for producing of mesenchymal stem cells and application thereof3 Sep 2026US 2026/0258367 A1Hunan Meibo Biomedical Co., Ltd
- Systems and methods for preservation of cells27 Aug 2026US 2026/0248123 A1University of Louisville Research Foundation, Inc.
- Composition and method for ex vivo expansion of stem cell memory t cells23 Jul 2026US 2026/0209700 A1Lukas Biomedical Inc.
- Method for differentiating platelets, culture medium, and use9 Jul 2026US 2026/0193610 A1Hemacell Biotechnology Inc.
- Method of preparing a mass culture of muscle precursor cells (mpcs) and uses thereof9 Jul 2026US 2026/0193612 A1UniversitäT ZüRich
Most cited
By later US patents
- Method of isolating mesenchymal stem cells associated with isolated megakaryocytes by isolating megakaryocytes42US 5,965,436 AOsiris Therapeutics, Inc. · 1999
- Platelet fraction deriving from placental blood6US 8,501,170 B2Fondazione IRCCS "Ca'Granda - Ospedale Maggiore Policlinico" · 2013
- Cell culture method for mesenchymal stem cells4US 11,685,899 B2Mesoblast International Sarl · 2023
- Methods and compositions for optimized expansion and implantation of mesenchymal stem cells4US 9,095,562 B2Regenerative Sciences, LLC · 2015
- Activating adipose-derived stem cells for transplantation4US 9,650,608 B2Medivet America, LLC · 2017